Janssen Gets $1M Risperdal Breast-Growth Verdict Flipped

Law360 (September 24, 2018, 6:33 PM EDT) -- A New York federal judge has overturned a $1 million verdict for a man who took Risperdal as a child and developed female breast tissue, agreeing with defendant Janssen that it could not have warned of the condition on the label and that the trial was biased by a lawyer's mention of his own childhood bullying.

U.S. District Judge Glenn Suddaby granted Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc.'s motion for judgment as a matter of law, saying the failure-to-warn claim of plaintiff Shaquil Byrd was preempted by federal law regarding the circumstances under which Janssen was allowed to change the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!